Atrial Fibrillation in Congenital Heart Disease

The increasing prevalence of AF in a growing population of adults with congenital heart disease (CHD) poses new challenges to clinicians involved in the management of these patients. Distinctive underlying anatomies, unique physiological aspects, a high diversity of corrective surgeries and associat...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Irene Martín de Miguel, Pablo Ávila
Formato: article
Lenguaje:EN
Publicado: Radcliffe Medical Media 2021
Materias:
Acceso en línea:https://doaj.org/article/0e90095e35ac40eea745cd52dc137249
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0e90095e35ac40eea745cd52dc137249
record_format dspace
spelling oai:doaj.org-article:0e90095e35ac40eea745cd52dc1372492021-12-04T16:04:02ZAtrial Fibrillation in Congenital Heart Disease10.15420/ecr.2020.411758-37641758-3756https://doaj.org/article/0e90095e35ac40eea745cd52dc1372492021-03-01T00:00:00Zhttps://www.ecrjournal.com/articleindex/ecr.2020.41https://doaj.org/toc/1758-3756https://doaj.org/toc/1758-3764The increasing prevalence of AF in a growing population of adults with congenital heart disease (CHD) poses new challenges to clinicians involved in the management of these patients. Distinctive underlying anatomies, unique physiological aspects, a high diversity of corrective surgeries and associated comorbidities can complicate clinical decision-making. In this review, the authors provide an overview of the current knowledge on epidemiology and pathophysiology, with a special focus on the differences to the non-CHD population and the clinical impact of AF in adults with CHD. Acute and long-term management strategies are summarised, including the use of antiarrhythmic drugs, catheter or surgical ablation and prophylaxis of thromboembolism. Finally, gaps of knowledge and potential areas of future research are highlighted.Irene Martín de MiguelPablo ÁvilaRadcliffe Medical MediaarticleDiseases of the circulatory (Cardiovascular) systemRC666-701ENEuropean Cardiology Review , Vol 16, Iss , Pp - (2021)
institution DOAJ
collection DOAJ
language EN
topic Diseases of the circulatory (Cardiovascular) system
RC666-701
spellingShingle Diseases of the circulatory (Cardiovascular) system
RC666-701
Irene Martín de Miguel
Pablo Ávila
Atrial Fibrillation in Congenital Heart Disease
description The increasing prevalence of AF in a growing population of adults with congenital heart disease (CHD) poses new challenges to clinicians involved in the management of these patients. Distinctive underlying anatomies, unique physiological aspects, a high diversity of corrective surgeries and associated comorbidities can complicate clinical decision-making. In this review, the authors provide an overview of the current knowledge on epidemiology and pathophysiology, with a special focus on the differences to the non-CHD population and the clinical impact of AF in adults with CHD. Acute and long-term management strategies are summarised, including the use of antiarrhythmic drugs, catheter or surgical ablation and prophylaxis of thromboembolism. Finally, gaps of knowledge and potential areas of future research are highlighted.
format article
author Irene Martín de Miguel
Pablo Ávila
author_facet Irene Martín de Miguel
Pablo Ávila
author_sort Irene Martín de Miguel
title Atrial Fibrillation in Congenital Heart Disease
title_short Atrial Fibrillation in Congenital Heart Disease
title_full Atrial Fibrillation in Congenital Heart Disease
title_fullStr Atrial Fibrillation in Congenital Heart Disease
title_full_unstemmed Atrial Fibrillation in Congenital Heart Disease
title_sort atrial fibrillation in congenital heart disease
publisher Radcliffe Medical Media
publishDate 2021
url https://doaj.org/article/0e90095e35ac40eea745cd52dc137249
work_keys_str_mv AT irenemartindemiguel atrialfibrillationincongenitalheartdisease
AT pabloavila atrialfibrillationincongenitalheartdisease
_version_ 1718372657616912384